Publications
- Development of versatile and potent monoquaternary reactivators of acetylcholinesterase2021 | Publication without faculty affiliation
- Reactivation potential of novel more lipophilic pralidoxime analogs2018 | Publication without faculty affiliation
- Universality of Oxime K203 for Reactivation of Nerve Agent-Inhibited AChE2015 | Publication without faculty affiliation
- Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition2024 | Faculty of Science, First Faculty of Medicine, Third Faculty of Medicine
- Differentiated SH-SY5Y neuroblastoma cells as a model for evaluation of nerve agent-associated neurotoxicity2023 | Faculty of Pharmacy in Hradec Králové, First Faculty of Medicine
- Structure-Guided Design of N-Methylpropargylamino- Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer's Disease2023 | Faculty of Pharmacy in Hradec Králové, Faculty of Science
- Highly selective butyrylcholinesterase inhibitors related to Amaryllidaceae alkaloids - Design, synthesis, and biological evaluation2023 | Faculty of Pharmacy in Hradec Králové
- Non-covalent acetylcholinesterase inhibitors: In vitro screening and molecular modeling for novel selective insecticides2022 | Publication without faculty affiliation
- Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonists2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Science
- Huprine Y-Tryptophan heterodimers with potential implication to Alzheimer's disease treatment2021 | Faculty of Pharmacy in Hradec Králové, First Faculty of Medicine
Loading network view...